NasdaqGM:KODBiotechs
Kodiak Sciences (KOD) Is Up 9.8% After Wider Loss, Going Concern Note And BLA Acceleration
Kodiak Sciences recently reported 2025 results showing a wider full-year net loss of US$229.97 million and disclosed that its auditor raised going concern doubts, even as the company filed an US$83.15 million shelf registration tied to an ESOP-related share offering.
In parallel, Kodiak reported past positive Phase 3 GLOW2 data for its Zenkuda biologic in diabetic retinopathy and moved to accelerate a multi-indication Biologics License Application, highlighting a sharp contrast between its...